GeneGo Working with UK's NIHR on CNS Pathways | GenomeWeb

NEW YORK (GenomeWeb News) – The United Kingdom's National Institute of Health Research will work with GeneGo in a collaboration that the company hopes will lead to development of a pathway analysis tool for the central nervous system.

GeneGo said it is working with NIHR's Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College London through its MetaMiner CNS Partnership Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.